The enhancement of cellular immunity in the 4T1 tumor model is also explained by other studies, in which tumor progression was associated with an increase in CD8+ Gzmb cells (38), CD8/CD4 equilibrium (39), and IFN-γ+ CD4 cells (40). Here, CD4 is linked to neoplasm.